Idiopathic Inflammatory Myopathy (IIM) Clinical Trials

25 clinical trials for Idiopathic Inflammatory Myopathy (IIM) across international registries, including 11 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease — RECRUITING · PHASE1
• RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy — RECRUITING · PHASE2
• A Study of KITE-363 in Participants With Refractory Autoimmune Diseases — RECRUITING · PHASE1
• OM336 in Seropositive Autoimmune Diseases — RECRUITING · PHASE1
• Phase 1 Study of HBI0101 CAR-T in Refractory B-Cell Autoimmune Diseases — RECRUITING · PHASE1
• GC012F Injection in Refractory Idiopathic Inflammatory Myopathy — RECRUITING · PHASE1
• Anti-CD19 IL-10/IL15 CAR-NK Cells in Refractory/Relapsed Autoimmune Diseases — RECRUITING · NA
• Safety Study of CC312 in Autoimmune Disease Patients — RECRUITING · PHASE1
• Clinical Assessment for Rheumatologic Disease - Research and Advancement in Safety and Efficacy — RECRUITING
• A Study of OL-108 in Relapsed/Refractory Autoimmune Diseases — RECRUITING · PHASE1
• A PHASE 3, SINGLE-ARM, MULTICENTER, OPEN-LABEL EXTENSION OF STUDY ARGX-113-2007 TO INVESTIGATE THE LONG-TERM SAFETY, TOLERABILITY, AND EFFICACY OF EFGARTIGIMOD PH20 SC IN PARTICIPANTS AGED 18 YEARS AND OLDER WITH ACTIVE IDIOPATHIC INFLAMMATORY MYOPATHY — RECRUITING · PHASE3
• A Study of CC-97540, CD-19-Targeted Nex-T CAR T Cells, in Participants With Severe, Refractory Autoimmune Diseases (Breakfree-1) — ACTIVE_NOT_RECRUITING · PHASE1
• C0251010 - A PHASE 3, MULTI-CENTER, OPEN-LABEL EXTENSION STUDY TO INVESTIGATE THE LONG-TERM SAFETY, TOLERABILITY, AND EFFICACY OF DAZUKIBART IN PARTICIPANTS WITH IDIOPATHIC INFLAMMATORY MYOPATHIES (INCLUDING PARTICIPANTS WITH DERMATOMYOSITIS OR POLYMYOSITIS) — TERMINATED · PHASE3
• Muscle Function and Effects of Repetitive Task Training in Patients With Inflammatory Myopaties — COMPLETED · NA
• A Study to Assess CLBR001+SWI019 in Subjects With Autoimmune Diseases — WITHDRAWN · PHASE1
• IMPT-514 in Systemic Lupus Erythematosus, Anca-associated Vasculitis, and Idiopathic Inflammatory Myopathy — TERMINATED · PHASE1
• GC012F in Patients With Autoimmune Diseases — NOT_YET_RECRUITING · PHASE1
• OPEN-LABEL, PHASE 1 STUDY TO ASSESS THE SAFETY, TOLERABILITY, PHARMACOKINETICS AND PHARMACODYNAMICS OF AZD5492 FOLLLOWING SINGLE-ASCENDING DOSE AND STEP-UP DOSE ADMINISTRATION TO ADULT PARTICIPANTS WITH SYSTEMIC LUPUS ERYTHEMATUS OR IDIOPATIC INFLAMMATORY MYOPATIES — NOT_YET_RECRUITING · PHASE1
• MYOPROSP - a Prospective Cohort Study in Myositis — ACTIVE_NOT_RECRUITING
• Intravenous immunoglobulin and prednisone vs. prednisone in newly diagnosed myositis: a double blind randomized clinical trial — OTHER · PHASE2
• A PHASE 2/3, RANDOMIZED, DOUBLE-BLINDED, PLACEBO-CONTROLLED, PARALLEL-GROUP, 2-ARM, MULTICENTER, OPERATIONALLY SEAMLESS STUDY TO EVALUATE THE EFFICACY, SAFETY, TOLERABILITY, PHARMACODYNAMICS, PHARMACOKINETICS, AND IMMUNOGENICITY OF EFGARTIGIMOD PH20 SC IN PARTICIPANTS AGED 18 YEARS AND OLDER WITH ACTIVE IDIOPATHIC INFLAMMATORY MYOPATHY — COMPLETED · PHASE2
• A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY AND SAFETY OF NIPOCALIMAB IN PARTICIPANTS WITH ACTIVE IDIOPATHIC INFLAMMATORY MYOPATHIES — COMPLETED · PHASE2
• A Case-control Study to Assess Risk of Coronary Heart Disease in Idiopathic Inflammatory Myopathy — COMPLETED
• Clinical Study of MMF in Treatment of IIM-ILD and Its Effect on Peripheral Blood Treg Cells — OTHER · PHASE4
• A PHASE 3, RANDOMIZED, DOUBLE-BLIND CLINICAL TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF ABATACEPT SC WITH STANDARD TREATMENT COMPARED TO STANDARD TREATMENT ALONE IN IMPROVING DISEASE ACTIVITY IN ADULTS WITH ACTIVE IDIOPATHIC INFLAMMATORY MYOPATHY (IIM) — COMPLETED · PHASE3

Refine this search